News headlines about Catamaran Corp (NASDAQ:CTRX) have trended somewhat negative recently, Accern reports. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Catamaran Corp earned a news impact score of -0.16 on Accern’s scale. Accern also assigned press coverage about the healthcare company an impact score of 47.5824255876265 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

TRADEMARK VIOLATION NOTICE: This piece was posted by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/08/10/catamaran-corp-ctrx-receiving-somewhat-critical-media-coverage-report-shows.html.

About Catamaran Corp

Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies.

Receive News & Ratings for Catamaran Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catamaran Corp and related companies with MarketBeat.com's FREE daily email newsletter.